Anthraquinones as a privileged scaffold in drug discovery targeting nucleotide-binding proteins

Research output: Contribution to journalShort survey

8 Citations (Scopus)

Abstract

Anthraquinones are condensed aromatic hydrocarbons found naturally in medicinal plants and known for their potential medical and dye applications. Anthraquinones were developed as P2 receptor antagonists and ectonucleotidase inhibitors and feature very different characteristic properties regarding the binding site for anthraquinones. This demonstrates that the anthraquinone scaffold appears to behave as a privileged structure in medicinal chemistry targeting nucleotide-binding proteins, and the substitution pattern, especially in the 4-position, can direct its interaction with specific targets. This article will cover the structure activity relationships of anthraquinones for three different targets: P2Y12 receptor, ecto-5′-nucleotidase and P2X2 receptor.

Original languageEnglish
Pages (from-to)1571-1577
Number of pages7
JournalDrug Discovery Today
Volume21
Issue number10
DOIs
Publication statusPublished - Oct 1 2016

Fingerprint

Anthraquinones
Drug Discovery
Drug Delivery Systems
Carrier Proteins
Nucleotides
Purinergic P2X2 Receptors
Aromatic Hydrocarbons
5'-Nucleotidase
Pharmaceutical Chemistry
Structure-Activity Relationship
Medicinal Plants
Coloring Agents
Binding Sites

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Anthraquinones as a privileged scaffold in drug discovery targeting nucleotide-binding proteins. / Baqi, Younis.

In: Drug Discovery Today, Vol. 21, No. 10, 01.10.2016, p. 1571-1577.

Research output: Contribution to journalShort survey

@article{84bdeac8226c4eb09d19d1486c749d29,
title = "Anthraquinones as a privileged scaffold in drug discovery targeting nucleotide-binding proteins",
abstract = "Anthraquinones are condensed aromatic hydrocarbons found naturally in medicinal plants and known for their potential medical and dye applications. Anthraquinones were developed as P2 receptor antagonists and ectonucleotidase inhibitors and feature very different characteristic properties regarding the binding site for anthraquinones. This demonstrates that the anthraquinone scaffold appears to behave as a privileged structure in medicinal chemistry targeting nucleotide-binding proteins, and the substitution pattern, especially in the 4-position, can direct its interaction with specific targets. This article will cover the structure activity relationships of anthraquinones for three different targets: P2Y12 receptor, ecto-5′-nucleotidase and P2X2 receptor.",
author = "Younis Baqi",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.drudis.2016.06.027",
language = "English",
volume = "21",
pages = "1571--1577",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Anthraquinones as a privileged scaffold in drug discovery targeting nucleotide-binding proteins

AU - Baqi, Younis

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Anthraquinones are condensed aromatic hydrocarbons found naturally in medicinal plants and known for their potential medical and dye applications. Anthraquinones were developed as P2 receptor antagonists and ectonucleotidase inhibitors and feature very different characteristic properties regarding the binding site for anthraquinones. This demonstrates that the anthraquinone scaffold appears to behave as a privileged structure in medicinal chemistry targeting nucleotide-binding proteins, and the substitution pattern, especially in the 4-position, can direct its interaction with specific targets. This article will cover the structure activity relationships of anthraquinones for three different targets: P2Y12 receptor, ecto-5′-nucleotidase and P2X2 receptor.

AB - Anthraquinones are condensed aromatic hydrocarbons found naturally in medicinal plants and known for their potential medical and dye applications. Anthraquinones were developed as P2 receptor antagonists and ectonucleotidase inhibitors and feature very different characteristic properties regarding the binding site for anthraquinones. This demonstrates that the anthraquinone scaffold appears to behave as a privileged structure in medicinal chemistry targeting nucleotide-binding proteins, and the substitution pattern, especially in the 4-position, can direct its interaction with specific targets. This article will cover the structure activity relationships of anthraquinones for three different targets: P2Y12 receptor, ecto-5′-nucleotidase and P2X2 receptor.

UR - http://www.scopus.com/inward/record.url?scp=84991383480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991383480&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2016.06.027

DO - 10.1016/j.drudis.2016.06.027

M3 - Short survey

C2 - 27373759

AN - SCOPUS:84991383480

VL - 21

SP - 1571

EP - 1577

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 10

ER -